Literature DB >> 19540241

Hic-5 is required for fetal gene expression and cytoskeletal organization of neonatal cardiac myocytes.

Erin E Yund1, Joseph A Hill, Rebecca S Keller.   

Abstract

Cardiac costameres link the extracellular matrix to the sarcomere at the z-disc and contain proteins such as integrins and other signaling molecules implicated in the regulation of pathological hypertrophy. Paxillin family members, hic-5 and paxillin, are scaffolding proteins associated with the integrin complex that have been shown to mediate numerous protein interactions in other cell types. While paxillin has been described in postnatal heart, hic-5 has not been identified. Our results provide evidence of hic-5 in neonatal cardiac myocytes co-localized with paxillin and alpha-actinin at the z-discs and the ends of actin filaments. Treatment with the hypertrophic agonist phenylephrine resulted in increased hic-5 expression while having no effect on paxillin levels. To see if increased hic-5 expression was sufficient to induce changes in cytoskeletal organization, hic-5 was overexpressed in myocytes by adenoviral infection. Hic-5 overexpression significantly increased the number of cells with organized cytoskeleton. Using siRNA mediated knockdown, we examined the requirement of hic-5 and paxillin in regulation of phenylephrine induced gene expression and cytoskeletal organization. Our results indicate that hic-5, not paxillin is required for upregulation of ANF and alpha-skeletal actin genes as well as in cytoskeletal reorganization. Finally, we demonstrated that hic-5 upregulation occurs downstream of MEK1/2-ERK1/2 signaling as inhibition of MEK1/2 using U0126 inhibitor completely inhibited hic-5 upregulation by PE. In a complimentary study, we showed that hic-5 knockdown had no effect on PE induced ERK1/2 phosphorylation. These findings demonstrate a novel role for hic-5 in the regulation of actin cytoskeleton and fetal gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540241      PMCID: PMC3427732          DOI: 10.1016/j.yjmcc.2009.06.006

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  30 in total

1.  Novel cell lines promote the discovery of genes involved in early heart development.

Authors:  E W Brunskill; D P Witte; K E Yutzey; S S Potter
Journal:  Dev Biol       Date:  2001-07-15       Impact factor: 3.582

2.  Involvement of Hic-5 in platelet activation: integrin alphaIIbbeta3-dependent tyrosine phosphorylation and association with proline-rich tyrosine kinase 2.

Authors:  M Osada; T Ohmori; Y Yatomi; K Satoh; S Hosogaya; Y Ozaki
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

3.  Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance.

Authors:  R S Keller; S Y Shai; C J Babbitt; C G Pham; R J Solaro; M L Valencik; J C Loftus; R S Ross
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  A role for focal adhesion kinase in phenylephrine-induced hypertrophy of rat ventricular cardiomyocytes.

Authors:  J M Taylor; J D Rovin; J T Parsons
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

5.  Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1.

Authors:  M A Sussman; S Welch; A Walker; R Klevitsky; T E Hewett; R L Price; E Schaefer; K Yager
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure.

Authors:  Shaw-Yung Shai; Alice E Harpf; Christopher J Babbitt; Maria C Jordan; Michael C Fishbein; Ju Chen; Michelle Omura; Tarek A Leil; K David Becker; Meisheng Jiang; Desmond J Smith; Simon R Cherry; Joseph C Loftus; Robert S Ross
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

7.  The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling.

Authors:  Margit Hagel; Elizabeth L George; Ann Kim; Rulla Tamimi; Sarah L Opitz; Christopher E Turner; Akira Imamoto; Sheila M Thomas
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

8.  Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.

Authors:  T L Yue; J L Gu; C Wang; A D Reith; J C Lee; R C Mirabile; R Kreutz; Y Wang; B Maleeff; A A Parsons; E H Ohlstein
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

9.  Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway.

Authors:  C G Pham; A E Harpf; R S Keller; H T Vu; S Y Shai; J C Loftus; R S Ross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

10.  Hic-5 promotes endothelial cell migration to lysophosphatidic acid.

Authors:  C Avraamides; M E Bromberg; J P Gaughan; S M Thomas; A Y Tsygankov; T S Panetti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-02       Impact factor: 4.733

View more
  8 in total

1.  Hic-5 is required for myofibroblast differentiation by regulating mechanically dependent MRTF-A nuclear accumulation.

Authors:  Scott D Varney; Courtney B Betts; Rui Zheng; Lei Wu; Boris Hinz; Jiliang Zhou; Livingston Van De Water
Journal:  J Cell Sci       Date:  2016-01-12       Impact factor: 5.285

2.  Transforming growth factor-β1-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor/myocardin protein.

Authors:  Xiaobo Wang; Guoqing Hu; Courtney Betts; Erin Yund Harmon; Rebecca S Keller; Livingston Van De Water; Jiliang Zhou
Journal:  J Biol Chem       Date:  2011-10-08       Impact factor: 5.157

3.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

4.  Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.

Authors:  Ming Chang Hu; Mingjun Shi; Han Jun Cho; Beverley Adams-Huet; Jean Paek; Kathy Hill; John Shelton; Ansel P Amaral; Christian Faul; Masatomo Taniguchi; Myles Wolf; Markus Brand; Masaya Takahashi; Makoto Kuro-O; Joseph A Hill; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2014-10-17       Impact factor: 10.121

5.  Calpain 2 activation of P-TEFb drives megakaryocyte morphogenesis and is disrupted by leukemogenic GATA1 mutation.

Authors:  Kamaleldin E Elagib; Jeremy D Rubinstein; Lorrie L Delehanty; Valerie S Ngoh; Peter A Greer; Shuran Li; Jae K Lee; Zhe Li; Stuart H Orkin; Ivailo S Mihaylov; Adam N Goldfarb
Journal:  Dev Cell       Date:  2013-12-23       Impact factor: 12.270

6.  Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.

Authors:  Ana Maria Manso; Ruixia Li; Susan J Monkley; Nathalia M Cruz; Shannon Ong; Dieu H Lao; Yevgeniya E Koshman; Yusu Gu; Kirk L Peterson; Ju Chen; E Dale Abel; Allen M Samarel; David R Critchley; Robert S Ross
Journal:  J Biol Chem       Date:  2012-12-24       Impact factor: 5.157

7.  Paxillin and Focal Adhesion Kinase (FAK) Regulate Cardiac Contractility in the Zebrafish Heart.

Authors:  Sofia Hirth; Anja Bühler; John B Bührdel; Steven Rudeck; Tillman Dahme; Wolfgang Rottbauer; Steffen Just
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

8.  ADAP1 limits neonatal cardiomyocyte hypertrophy by reducing integrin cell surface expression.

Authors:  Hugo Giguère; Audrey-Ann Dumont; Jonathan Berthiaume; Vanessa Oliveira; Gino Laberge; Mannix Auger-Messier
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.